Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Cash Flow Reinvestment Rate
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Cash Flow Reinvestment Rate of 0.46x as of September 2025, reinvesting CN¥32.02 Million (capex CN¥32.02 Million ) from operating cash flow of CN¥69.15 Million. Explore capital reinvestment ratio of Anhui Fengyuan Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Anhui Fengyuan Pharmaceutical Co Ltd across 24 annual periods. Also explore 000153 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Anhui Fengyuan Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 000153 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.27x | CN¥270.65 Million | CN¥119.30 Million | CN¥220.61 Million | ▲ +13.7% |
| 2024 | 2.00x | CN¥251.93 Million | CN¥126.24 Million | CN¥144.02 Million | ▲ +222.8% |
| 2023 | 0.62x | CN¥157.48 Million | CN¥254.75 Million | CN¥152.12 Million | ▲ +150.1% |
| 2022 | 0.25x | CN¥108.76 Million | CN¥439.99 Million | CN¥81.76 Million | ▼ -64.2% |
| 2021 | 0.69x | CN¥164.26 Million | CN¥237.88 Million | CN¥157.36 Million | ▼ -25.2% |
| 2020 | 0.92x | CN¥270.07 Million | CN¥292.75 Million | CN¥190.74 Million | ▼ -83.3% |
| 2019 | 5.54x | CN¥366.62 Million | CN¥66.21 Million | CN¥145.62 Million | ▲ +600.4% |
| 2018 | 0.79x | CN¥184.65 Million | CN¥233.59 Million | CN¥84.63 Million | ▼ -21.3% |
| 2017 | 1.00x | CN¥52.60 Million | CN¥52.40 Million | CN¥47.99 Million | ▲ +70.2% |
| 2016 | 0.59x | CN¥46.15 Million | CN¥78.21 Million | CN¥22.17 Million | ▼ -47.8% |
| 2015 | 1.13x | CN¥51.43 Million | CN¥45.50 Million | CN¥50.33 Million | ▼ -93.2% |
| 2014 | 16.73x | CN¥175.86 Million | CN¥10.51 Million | CN¥175.86 Million | ▲ +703.5% |
| 2012 | 2.08x | CN¥95.06 Million | CN¥45.65 Million | CN¥95.06 Million | ▲ +64.1% |
| 2011 | 1.27x | CN¥69.86 Million | CN¥55.06 Million | CN¥69.86 Million | ▼ -22.2% |
| 2010 | 1.63x | CN¥89.75 Million | CN¥55.04 Million | CN¥89.75 Million | ▼ -29.0% |
| 2009 | 2.30x | CN¥74.42 Million | CN¥32.41 Million | CN¥74.42 Million | ▲ +262.3% |
| 2008 | 0.63x | CN¥31.58 Million | CN¥49.82 Million | CN¥31.58 Million | ▼ -0.4% |
| 2007 | 0.64x | CN¥35.18 Million | CN¥55.26 Million | CN¥35.18 Million | ▼ -83.1% |
| 2006 | 3.77x | CN¥136.67 Million | CN¥36.27 Million | CN¥136.67 Million | ▲ +268.4% |
| 2005 | 1.02x | CN¥35.68 Million | CN¥34.88 Million | CN¥35.68 Million | ▼ -88.3% |
| 2002 | 8.73x | CN¥91.40 Million | CN¥10.48 Million | CN¥91.40 Million | ▲ +8.1% |
| 2001 | 8.07x | CN¥190.24 Million | CN¥23.57 Million | CN¥190.24 Million | ▲ +77.3% |
| 2000 | 4.55x | CN¥117.82 Million | CN¥25.88 Million | CN¥117.82 Million | ▲ +0.5% |
| 1999 | 4.53x | CN¥4.59 Million | CN¥1.01 Million | CN¥4.59 Million | — |